Long-term Survival Outcomes of Advanced Gastric Cancer Patients Who Achieved a Pathological Complete Response with Neoadjuvant Chemotherapy: A Systematic Review of the Literature

Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis

(2014) A. Tsuburaya et al.   BRITISH JOURNAL OF SURGERY

Impact of pathologic complete response on disease-free survival in patients with esophagogastric adenocarcinoma receiving preoperative docetaxel-based chemotherapy

(2013) S. Lorenzen et al.   ANNALS OF ONCOLOGY

Induction of a Pathological Complete Response by Four Courses of Neoadjuvant Chemotherapy for Gastric Cancer: Early Results of the Randomized Phase II COMPASS Trial

(2013) Takaki Yoshikawa et al.   ANNALS OF SURGICAL ONCOLOGY

Validity of response assessment criteria in neoadjuvant chemotherapy for gastric cancer (JCOG0507-A)

(2013) Yukinori Kurokawa et al.   Gastric Cancer

Neoadjuvant chemotherapy for gastric cancer in Japan: a standing position by comparing with adjuvant chemotherapy

(2013) Takaki Yoshikawa et al.   SURGERY TODAY

A Prospective Validation Study to Diagnose Serosal Invasion and Nodal Metastases of Gastric Cancer by Multidetector-row CT

(2012) Shinichi Hasegawa et al.   ANNALS OF SURGICAL ONCOLOGY

Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry

(2012) Atsushi Nashimoto et al.   Gastric Cancer

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

(2012) Yung-Jue Bang et al.   LANCET

Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma

(2011) R C Fields et al.   BRITISH JOURNAL OF CANCER

A multicenter phase II study of combined chemotherapy with docetaxel, cisplatin, and S-1 in patients with unresectable or recurrent gastric cancer (KDOG 0601)

(2011) Wasaburo Koizumi et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial

(2011) Marc Ychou et al.   JOURNAL OF CLINICAL ONCOLOGY

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

(2010) Yung-Jue Bang et al.   LANCET

Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer

(2009) T. Yoshikawa et al.   BRITISH JOURNAL OF SURGERY

Phase III Comparison of Preoperative Chemotherapy Compared With Chemoradiotherapy in Patients With Locally Advanced Adenocarcinoma of the Esophagogastric Junction

(2009) Michael Stahl et al.   JOURNAL OF CLINICAL ONCOLOGY

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

(2008) Wasaburo Koizumi et al.   LANCET ONCOLOGY